Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-2.87M.
ENTERPRISE VALUE (EV)
$-2.87M
NextCure, Inc.
Market Cap
$18.96M
Enterprise Value (EV)
$-2.87M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| NextCure, Inc. (NXTC) | $18.96M | $-2.87M |
| P3 Health Partners Inc. (PIII)vs › | $19.66M | $128.66M |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.54M | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $20.03M | $16.01M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.40M | $18.25M |
| PAVmed Inc. (PAVM)vs › | $18.31M | $31.59M |
| Modular Medical, Inc. (MODD)vs › | $20.38M | $16.74M |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.54M | $17.86M |
| Cosmos Health Inc. (COSM)vs › | $17.65M | $31.82M |
| Lipocine Inc. (LPCN)vs › | $17.19M | $12.21M |
Market Cap
$18.96M
Total Debt
$4.15M
Cash
$25.98M
Enterprise Value
$-2.87M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
